Discovery of natural antibody offers hope for a near-universal flu vaccine
Ian Wilson, the Hansen Professor of Structural Biology and a member of the Skaggs Institute for Chemical Biology at Scripps Research
Article Summary
Every year in the lead up to flu season, those at high risk of infection, such as the young, the elderly and those who are immune-compromised, head off to the doctor for a jab in the hopes it will protect them from the flu. However, influenza vaccines have a number of shortcomings that means even those who have been vaccinated may still get influenza. Researchers at the Scripps Research Institute and Dutch biopharmaceutical company Crucell have now found a broadly acting antibody that could lead to a single, near-universal flu vaccine to replace annually changing vaccines.
« Back to Discovery of natural antibody offers hope for a near-universal flu vaccine
Related Articles
